Best Stocks of 2017: Zynerba Pharmaceuticals Inc Is a Perfect Prescription

Best Stocks of 2017: Zynerba Pharmaceuticals Inc. Is a Perfect Prescription

Flickr / David Gach / CC BY 2.0

This is the cleaner side of marijuana. And one small biotech company — Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) — has figured out how to synthetically manufacture the plant’s two defining compounds, cannabinoid and tetrahydrocannabinol, then deliver to them to patients as a wearable patch or topical gel.

Zynerba has been getting a lot of attention recently, more than most companies valued at just $139 million.

View Original Article Here

Repost is the designation for articles collected from the Internet whose content may interest our readers. These articles are not written by our staff and they do not necessarily reflect our views.

Related posts